February 15, 2022
Authored and Edited by Troy V. Viger; Joshua L. Goldberg
In Intuitive Surgical, Inc. v. Ethicon LLC, No. 2020-1481 (Fed. Cir. Feb. 11, 2022), the Federal Circuit affirmed that Intuitive was estopped under § 315(e)(1) from maintaining an IPR and dismissed the appeal.
Intuitive simultaneously filed three IPRs challenging the patentability of Ethicon’s patent, each relying on different prior art references, yet each attacking the same claims. The Board issued final written decisions in two of the IPRs. Later, in the third, the Board removed Intuitive as a petitioner because § 315(e)(1) estopped Intuitive after issuance of the two final written decisions.
Intuitive argued § 315(e)(1) estoppel should not apply to simultaneously filed petitions. The Court rejected Intuitive’s argument that it could not “reasonably have raised” all its grounds in two IPR petitions because of word limits. The Federal Circuit also noted that Intuitive had alternative avenues that would have allowed it to file three full-length petitions while avoiding the consequences of § 315(e)(1). It could have sought consolidation or focused each petition on a separate set of claims.
Intuitive also argued it may appeal the Board’s decision because it was once a party to an IPR. The Federal Circuit concluded that once § 315(e)(1) estopped Intuitive, it ceased to be a party, and lost any right to appeal.
Copyright © 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.